APA (7th ed.) Citation

T, S., BL, H., R, W., T, I., & K, T. (2025). ASO Author Reflections: Is Mesothelin a Promising Option for Molecular Targeted Therapies in Triple Negative Breast Cancer? Annals of surgical oncology, 32(8), 6106. https://doi.org/10.1245/s10434-025-17314-9

Chicago Style (17th ed.) Citation

T, Sato, Hagerty BL, Wu R, Ishikawa T, and Takabe K. "ASO Author Reflections: Is Mesothelin a Promising Option for Molecular Targeted Therapies in Triple Negative Breast Cancer?" Annals of Surgical Oncology 32, no. 8 (2025): 6106. https://doi.org/10.1245/s10434-025-17314-9.

MLA (9th ed.) Citation

T, Sato, et al. "ASO Author Reflections: Is Mesothelin a Promising Option for Molecular Targeted Therapies in Triple Negative Breast Cancer?" Annals of Surgical Oncology, vol. 32, no. 8, 2025, p. 6106, https://doi.org/10.1245/s10434-025-17314-9.